English

More about this topic

Business Line

Uzbekistan expands pharma production with €1.2bn investment

In partnership with Center for the Production of Content for Mass Media under the Administration of the President of the Republic of Uzbekistan

Uzbekistan is rapidly scaling up its pharmaceutical sector with the launch of Tashkent Pharma Park — a €1.2 billion project uniting research, logistics, manufacturing and training.

Health news

Meet the company leveraging AI-backed physics tools for drug discovery

The start-up aims to use AI to drastically reduce the time and money it takes to develop new drugs.

Health news

Novo Nordisk CEO steps down amid competition for weight loss drugs

Lars Fruergaard Jørgensen, who has led the pharmaceutical giant since 2017, joined the firm in 1991.

Healthcare

Which countries in Europe pay the most for medicines?

Europeans pay different prices for medicines based on where exactly they live, but they spend way less than the US does.

ADVERTISEMENT

Business

Bayer shares soar as company records strong cancer drug demand

Bayer’s strong first quarter performance was mainly driven by its pharmaceuticals division, even as its crop-science branch lagged.

Business

Novo Nordisk cuts forecast as weight-loss drug competition heats up

Novo Nordisk shares jumped following stronger-than-expected first-quarter earnings, despite the company lowering its growth outlook for 2025 amid intensifying competition in the weight-loss drug markets.

Health news

EU holds firm on pharma reform proposal despite industry pressure

The European Commission has no plans to withdraw or revise its proposed overhaul of EU pharmaceutical rules, despite mounting pressure from the pharmaceutical industry concerned about potential tariffs and the sector’s competitiveness.

Health news

Tariff treatment: Six diagnoses for EU pharma sector amid US trade war

Potential US tariffs on pharmaceuticals could set off a ripple effect that extends far beyond the immediate price hikes, as both the US and Europe heavily rely on each other.

Europe News

Who should pay for urban wastewater treatment?

The pharmaceutical and cosmetics industries have gone to the EU's court to challenge a directive that requires them to finance at least 80% of urban wastewater treatment.

Business

Bayer ordered to pay €1.9 billion by US court in Roundup cancer case

Pharmaceutical company Bayer took over weed killer Roundup in its acquisition of US agrochemical company Monsanto back in 2018. However, it has since been hit with thousands of cancer-related Roundup cases.

Health news

5 takeaways on the Critical Medicines Act

From funding challenges to what changes in joint drug procurement: Here’s what you need to know about the new rules aimed at securing Europe's access to critical medicines.

Economy

Here’s why Trump’s tariffs could hit Ireland’s pharma sector hardest

The Irish economy is particularly vulnerable to US tariffs against the EU, as it exports relatively more to the US compared to other EU economies.

Health news

Big pharma urges Commission to slow down new critical medicines rules

With the date of publication for a Critical Medicines Act fast approaching, the EU’s pharma industry is urging the Commission to slow down rather than keeping to a promise made by Health Commissioner Oliver Várhelyi to launch the proposal within the first 100 days of his mandate.

Business

AstraZeneca reports strong results boosted by promising trials

AstraZeneca continued to see strong growth in 2024 on the back of a series of positive trials, as well as a solid pipeline of products.

Business

Novo Nordisk reports positive next-generation obesity drug trial

Novo Nordisk announced positive trial results for its next-generation obesity drug, leading to a 7.13% surge in its share price on Friday.

Healthcare

Europe launches medicine shortage monitoring in 2025

Among the health policy novelties of 2025, a new tool developed by the European Medicines Agency (EMA) is set to harmonise monitoring of medicine shortages across Europe.

Business

Sanofi announces its largest China investment amid ongoing trade war

The French pharma firm is seeking to increase insulin production in Beijing as trade tensions between the EU and China simmer on.

Business

Bayer shares fall as pharma giant’s results fail to cheer investors

Bayer’s share price fell on Tuesday, following the company releasing lacklustre third quarter earnings with a warning that the current challenges may also impact next year’s results as well.

Business

AstraZeneca beats expectations and raises guidance despite China woes

AstraZeneca raises its fiscal 2024 guidance for the second consecutive quarter. This upgrade comes despite ongoing legal challenges in China as it reported robust third-quarter earnings results.

Business

CVC Capital Partners seeks cash injection for Italian pharma group

The private equity business is reported to be looking for a buyer to take on its majority stake in Genetic Group, an Italian pharmaceutical contract manufacturing company.